Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results
暂无分享,去创建一个
J. Mellors | A. Collier | E. Acosta | K. Klingman | S. Eshleman | A. Kashuba | E. Vergis | Gerald F Downey | C. Tierney | T. Scott